GlaxoSmithKline patient assistance programs provided medicines valued at almost $438 million (Wholesale Acquisition Cost) to more than 415,000 patients during 2008.

Commitment to Access provides free GSK oncology and specialty pharmacy medicines to eligible low-income patients without prescription drug benefits. Commitment to Access also accepts eligible patients with Medicare Part D or insurance that offers generic-only drug benefits. Patients must meet certain eligibility criteria to qualify for assistance and must enroll in Commitment to Access with the help of an advocate.

Eligibility for Commitment to Access is determined during the phone enrollment. See the application for additional information.